110
Participants
Start Date
September 11, 2024
Primary Completion Date
January 30, 2026
Study Completion Date
January 30, 2026
Screening with swallowable esophageal cell-collection devices (SECD)
All participants who enroll in this study and provide their consent will undergo screening with an FDA approved swallowable esophageal cell-collection device (SECD)
OHSU Knight Cancer Institute, Portland
Collaborators (1)
Kuni Foundation
UNKNOWN
Oregon Health and Science University
OTHER
OHSU Knight Cancer Institute
OTHER